Company Filing History:
5 out of 120 
6 out of 832,891 Years Active: 1999-2005
Title: Paul J Conlon: Innovator in Diabetes and Multiple Sclerosis Treatments
Introduction
Paul J Conlon is a notable inventor based in Solana Beach, CA (US). He has made significant contributions to the fields of diabetes and multiple sclerosis treatment through his innovative research and development. With a total of 11 patents, Conlon has established himself as a key figure in medical advancements.
Latest Patents
Conlon's latest patents include groundbreaking methods for the treatment of diabetes using peptide analogues of insulin. This invention focuses on peptide analogues derived from the B chain of insulin, specifically altering residues at positions 12, 13, 15, and/or 16. These modifications aim to enhance the efficacy of the treatment for diabetes. Additionally, he has developed methods for treating multiple sclerosis using peptide analogues that modify residue 91 of human myelin basic protein. These pharmaceutical compositions are designed to provide therapeutic benefits to patients suffering from multiple sclerosis.
Career Highlights
Throughout his career, Conlon has worked with various companies, including Neurocrine Biosciences, Inc. His work has been instrumental in advancing medical treatments and improving patient outcomes. His innovative approaches have garnered attention in the scientific community and have contributed to the development of effective therapies.
Collaborations
Conlon has collaborated with notable professionals in his field, including Amitabh Gaur and Nicholas C Ling. These partnerships have facilitated the exchange of ideas and have furthered research in the areas of diabetes and multiple sclerosis.
Conclusion
Paul J Conlon's contributions to medical science through his patents and collaborations highlight his dedication to improving healthcare. His innovative methods for treating diabetes and multiple sclerosis demonstrate the impact of his work on patient care and medical advancements.